Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® et Liflow®, announces its consolidated IFRS half-year results for 2024.

Guerbet (FR0000032526 GBT), worldwide leader in medical imaging, and Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announce the CE marking under MDR of the liver AI developed by Guerbet (trading name: DUOnco™ Liver).

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and Myrian^® and Liflow^® developer, announces its attendance in Journées Francophones de Radiologie (JFR) 2024, where will be presented for the first time the new solution Liflow^® as well as the innovations of the new version of Myrian^®.

The Board of Directors of Intrasense (FR0011179886 - ALINS), metting on August, 28 2024 at 5:30 pm under the chairmanship of Mr. François NICOLAS, has decided to appoint Mr. Alexandre SALVADOR as Chief Executive Officer of Intrasense.

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^® (the "Company"), today announced its half-year revenue for 2024 IFRS consolidated at Group level.